For the 20th consecutive season, the ZiPS projection system is unleashing a full set of prognostications. For more information on the ZiPS projections, please consult this year’s introduction and MLB’s glossary entry. The team order is selected by lot, and the next team up is the Texas Rangers.

Batters

The Rangers led the American League in runs scored in 2023, and most of the players who contributed to that success are set to return to the lineup in 2024. Sure, Corey Seager might not repeat his monster season, but his performance should still land comfortably in star territory, and the Rangers could get a little luckier with his health. Evan Carter isn’t likely to post an OPS around 1.000 again, but that’s balanced by the fact that the team ought to get a lot more than 23 regular season games from him this year. Read the rest of this entry »

Troy Taylor is an under-the-radar pitcher to keep your eye on in the Seattle Mariners system. A 22-year-old right-hander who was taken in the 12th round of the 2022 draft out of the University of California Irvine, Taylor impressed evaluators in the Arizona Fall League with a two-pitch mix that has him well-positioned for a future role as a big-league reliever.

“I’m a big fan of what he can do athletically, as a mover,” said a scout I spoke to. “His stuff is good. He’s a guy who probably ends up in the bullpen with the Mariners, and sooner rather than later.”

He’s already come a long way. Taylor was an infielder at Rancho Cucamonga’s Los Osos High School, and when he did occasionally take the mound — “I closed a couple of times” — all he really did was throw as hard he could. It wasn’t until he got to Cyprus Junior College, and then to UC-Irvine, that he “actually started learning how to pitch.”

Taylor has understandably learned a lot more about the nuances of his craft since signing with Seattle, but he nonetheless remains anything but a technician. Topping out at 98 mph and typically averaging “five and some change,” he still tries to throw his heater as hard as he can. He identifies as a power pitcher.

Adding a third pitch is a goal — the Mariners have him working on a changeup to use against left-handed hitters — but his fastball-slider combination will always be his bread and butter. The former is not only his best pitch, it has unique characteristics. Read the rest of this entry »

Rhys Hoskins is a free agent, and it’s kind of weird. The 30-year-old first baseman spent 10 seasons in the Phillies organization, six of them (plus one full year spent on the injured list) with the major league club. For a time, he was one of the only bright spots on a completely moribund team, but eventually the big fella settled into a role as a supporting player and de facto table-setter for a lineup built around Bryce Harper. His achievements in that role include the Bat Spike home run, a three-run dinger off Spencer Strider in the 2022 NLDS — the Phillies’ first home playoff game in 11 years.

While it was surpassed in the imagination by Harper’s pennant-winning homer in the rain later that October, the image of Hoskins’ celebration lives on in memory as a highly localized version of the José Bautista bat flip for people who are deeply upset by the decline in the quality of Wawa’s sandwich bread since the chain went national. You want to watch the home run again? I do. Let’s watch it again.

Read the rest of this entry »

The Rangers have a problem you don’t see every day. They have three pitchers, each likely out until halfway through this season, who all look like surefire starters when healthy. Jacob deGrom and Max Scherzer need no introduction; deGrom is looking at an August or September return, while Scherzer will likely be back in July. Add Tyler Mahle to the list, too: the Rangers signed him to a two-year, $22 million deal this offseason, but he won’t be fully recovered from Tommy John surgery until around midyear.

Let’s get the easy caveat out of the way: it’s not clear how good any of these three will be in 2024. Scherzer and Mahle weren’t exactly setting the world on fire before they got injured, and deGrom is coming off a nerve wracking second TJ. But I think it’s reasonable to look at that trio and see at least two elite starters. A rotation with a healthy deGrom, Scherzer, and Mahle at the top would probably be one of the best in baseball. That doesn’t even account for Nathan Eovaldi and the rest of the team’s arms – Jon Gray looked pretty good in his own return from injury this past October.

That starting five sounds incredible to me. There’s room for one of those pitchers to get hurt – and with that collection of guys, one of them getting hurt seems likely – and still have a fearsome playoff rotation. That’s almost certainly the team’s plan – signing deGrom is one thing, but signing an already-hurt Mahle makes it pretty clear that they’re building in some injury tolerance and aiming for the postseason. I like the plan – look no further than the Braves and Dodgers to see how teams struggle to find top tier pitching to pair with excellent offenses. But it does raise a question: What do they do for the first three months of the season? Read the rest of this entry »

The following article is part of Jay Jaffe’s ongoing look at the candidates on the BBWAA 2024 Hall of Fame ballot. For a detailed introduction to this year’s ballot, and other candidates in the series, use the tool above; an introduction to JAWS can be found here. For a tentative schedule and a chance to fill out a Hall of Fame ballot for our crowdsourcing project, see here. All WAR figures refer to the Baseball-Reference version unless otherwise indicated.

The fourth and final multi-candidate pairing of this series is by far the heaviest, covering two candidates who have both been connected to multiple incidents of domestic violence. Read the rest of this entry »

The Rangers love a free-agent starting pitcher: Jacob deGrom, Nathan Eovaldi, Jon Gray, Andrew Heaney, Martín Pérez. And now Tyler Mahle. The 29-year-old righthander, previously of the Reds and Twins, has signed a two-year, $22 million contract with the Rangers. He will make $5.5 million in 2024 and $16.5 million in ’25, plus up to an additional $5 million in incentives depending on how many innings he throws in the latter season.

This news, which was exciting enough to draw approximately zero eyeballs away from the Shohei Ohtani introductory presser that started half an hour later, is a shrewd signing by the reigning world champions. I encourage you to click More and read anyway, but I’ll give away the ending, I don’t care: I really like this deal for the Rangers, as well as Mahle’s fit with the team. Read the rest of this entry »

The following article is part of Jay Jaffe’s ongoing look at the candidates on the BBWAA 2024 Hall of Fame ballot. For a detailed introduction to this year’s ballot, and other candidates in the series, use the tool above; an introduction to JAWS can be found here. For a tentative schedule and a chance to fill out a Hall of Fame ballot for our crowdsourcing project, see here. All WAR figures refer to the Baseball-Reference version unless otherwise indicated.

As befits a player who spent 21 seasons in the majors and ranks 15th all-time in games played, Adrián Beltré really had two careers. In the first one, he was the prodigy who didn’t quite live up to expectations. Signed (illegally) by the Dodgers out of the Dominican Republic at age 15, he reached the majors at 19, became a free agent at 25 after one of the greatest walk years of all time, and disappointed at his next stop in Seattle. Through his age-30 season, he hadn’t made a single All-Star team, and he’d played in just one postseason series.

In his second career, which began with a brief stop in Boston before a longer stay in Texas, Beltré was a well-decorated and even beloved superstar. His elite defense carried over, and he emerged as a prolific slugger with exceptional contact skills, a team leader, and a fan favorite who won five Gold Gloves and made four All-Star teams while helping the Rangers to four playoff appearances and a pennant. He became the first Dominican-born player to reach the 3,000-hit milestone, as well as the career leader in hits among players born outside the United States, a surefire Hall of Famer in waiting. Read the rest of this entry »

The following article is part of Jay Jaffe’s ongoing look at the candidates on the BBWAA 2024 Hall of Fame ballot. For a detailed introduction to this year’s ballot, and other candidates in the series, use the tool above; an introduction to JAWS can be found here. For a tentative schedule and a chance to fill out a Hall of Fame ballot for our crowdsourcing project, see here. All WAR figures refer to the Baseball-Reference version unless otherwise indicated.

In my previous multi-candidate roundup, I paired two lefties who haven’t gotten much traction on Hall of Fame ballots thus far in Andy Pettitte and Mark Buehrle. As a means of completing my coverage of the major candidates before the December 31 voting deadline, it made sense to group them into a single overview and invite readers wishing to (re)familiarize themselves with the specifics of their cases to check out last year’s profiles. Today, I’m doing the same for a pair of elite hitters who would already be enshrined if not for their links to performance-enhancing drugs: Manny Ramirez and Alex Rodriguez.

Like Barry Bonds and Roger Clemens, both sluggers have transgressions that predate the introduction of drug testing and penalties in 2004. Via The New York Times (Ramirez) and Sports Illustrated (Rodriguez), both reportedly failed the supposedly anonymous 2003 survey test that determined whether such testing would be introduced. Had they not pressed their luck further, both might already be in Cooperstown alongside 2022 honoree David Ortiz, who reportedly failed the survey test, too. Alas, Ramirez was actually suspended twice, in 2009 and ’11; the latter ended his major league career, though he traveled the globe making comeback attempts. Rodriguez was suspended only once, but it was for the entire 2014 season due to his involvement in the Biogenesis scandal and his scorched-earth attempt to evade punishment.

Ramirez debuted with 23.8% on the 2017 ballot and only last year topped 30%. Rodriguez debuted with 34.3% in 2022 but barely inched up in ’23. Given that Bonds and Clemens topped out in the 65–66% range in 2022 and then were passed over by the Contemporary Baseball Era Committee the following year, nobody should be holding their breaths for these two to get elected anytime soon. Read the rest of this entry »

As the leading lights of the baseball world sit around Nashville, Tennessee, waiting for Shohei Ohtani to choose his forever home, the reliever market finally sputtered to life on Day 2 of the Winter Meetings, with two veteran right-handers signing contracts for 2024. Kirby Yates, late of the Braves, is bound for Texas on a one-year, $4.5 million deal. Chris Devenski, meanwhile, re-signed with the Rays on a one-year deal with a team option; the first year will pay him $1 million, after which the team holds a $2 million option with a $100,000 buyout.

As much as a balky bullpen can derail an otherwise championship-caliber team, the 2023 Rangers were the kind of club that makes you think the whole thing just isn’t worth worrying about. Texas won the World Series with a relief corps that did not fit its implacable offense, posting the worst strikeout rate of any playoff bullpen. The only team whose relievers fared worse on an ERA basis was Miami, and the Marlins lasted all of two games against a Phillies lineup that thrashed them around like a hungry cat tormenting a lizard. Read the rest of this entry »

Before Ben Clemens puts together the official Top 50 Free Agents list, he posts a rough draft in Slack and asks for everyone’s opinion. I, personally, didn’t give him much in the way of feedback, because he’s a floating brain in a jar and I’m the guy who’s mostly interested in baseball as a conduit for making stupid jokes in headlines. As long as Shohei Ohtani is no. 1, I’m good. Beyond that, I trust Ben. He knows more than I do anyway.

With that said, I do want to share what little feedback I did offer, because I’ve been thinking about this for weeks: “I have no idea where Mitch Garver should go. I balked at him being as high as no. 18 and then immediately started talking myself into putting him closer to 10.” (Garver was 18th on the first list I saw; he migrated up a spot by the time it was published.)

So let’s do it. Let’s talk ourselves into Mitch Garver as a top-10 free agent. Read the rest of this entry »